These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2192985)

  • 1. [Control of the emesis induced by cisplatin in patients with head and neck neoplasms. Randomized study of metoclopramide alizapride and placebo].
    Denaro A; Rossi M; Garozzo A; Matera M; Neri V
    G Ital Oncol; 1990; 10(1-2):29-34. PubMed ID: 2192985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
    Saller R; Hellenbrecht D
    Cancer Treat Rep; 1985 Nov; 69(11):1301-3. PubMed ID: 3912040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase I study of alizapride in cancer patients treated with cisplatin].
    Nicaise C; Rozencweig M; Ortmans M; Frisque C; Bleiberg H
    Sem Hop; 1983 Sep; 59(31):2161-5. PubMed ID: 6312589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy].
    Budach V; Krüger K
    Fortschr Med; 1983 Oct; 101(39):1792-4. PubMed ID: 6642386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alizapride in upper digestive endoscopy. A double-blind study vs metoclopramide and placebo].
    Bongiorno A; Cataldo MG; Salvia A; D'Aiuto A; Ciranni C
    Minerva Dietol Gastroenterol; 1989; 35(4):265-8. PubMed ID: 2695861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
    Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
    Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
    Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
    Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative double-blind study: alizapride-metoclopramide].
    Oberling F
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):59-61. PubMed ID: 6529162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
    Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study.
    Seng KT; Tiong CE; Hiang TC
    Br J Clin Pharmacol; 1994 Sep; 38(3):282-4. PubMed ID: 7826833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of nephrotoxicity by hydration-diuresis, and of emesis by alizapride, during cisplatin administration in patients with bladder cancer.
    Neri B; Bartalucci S; Rizzo P; Nicita G; Ponchietti R
    Riv Eur Sci Med Farmacol; 1988 Nov; 10(5):389-92. PubMed ID: 3079128
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
    J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients].
    Kagami Y; Nishio M; Narimatsu N; Tomita M; Sakurai T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):807-10. PubMed ID: 2712578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of antiemetic effect of clonazepam, metoclopramide, dexamethasone and diphenhydramine for prevention of cisplatin-induced vomiting].
    Hatae M; Nakamura Y; Mitsuo M; Sakurai K; Asano H; Onishi Y; Hokanishi H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1495-9. PubMed ID: 2389945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
    Padrón F; Sanz J; Flórez J
    Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
    [No Abstract]   [Full Text] [Related]  

  • 19. [Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis].
    Sawamura N; Funaki Y; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Yoshioka S; Sakurai M; Eguchi K
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):943-6. PubMed ID: 3885865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.